Actively Recruiting
Integrating Pediatric Pharmacogenomic Testing Into the Canadian Health Care System
Led by University of British Columbia · Updated on 2026-05-01
150
Participants Needed
2
Research Sites
418 weeks
Total Duration
On this page
Sponsors
U
University of British Columbia
Lead Sponsor
G
Genome British Columbia
Collaborating Sponsor
AI-Summary
What this Trial Is About
This project addresses the problem of adverse drug reactions in the three most frequently prescribed therapeutic classes of drugs in children: antibiotics, analgesics, and mental health medications. We will conduct pilot testing of a pharmacogenomic testing panel and study how the tests and generated test results are utilized and understood by physicians, pharmacists, patients and their families.
CONDITIONS
Official Title
Integrating Pediatric Pharmacogenomic Testing Into the Canadian Health Care System
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Participants must be considered for or currently using medications included in the pharmacogenomic testing panels (analgesics, antibiotics, mental health medications)
You will not qualify if you...
- Patients who do not speak or understand English
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Children's and Women's Health Centre of British Columbia
Vancouver, British Columbia, Canada, V6H 3V4
Actively Recruiting
2
Children's Hospital of Eastern Ontario
Ottawa, Ontario, Canada, K1H 8L1
Actively Recruiting
Research Team
B
Bruce Carleton, PharmD.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here